On day 0, 100,000 NT or GRAMD1B shRNA SKMEL2 cells were pretreated in 4 μg/mL dox-containing media in 6-well dishes to induce GRAMD1B knockdown for 48 hours. On day 2, cells were switched to either dox-containing control media (DMEM, 10% FBS, 1% antibiotics, 4 μg/mL dox) or cholesterol depletion media (DMEM, 10% lipoprotein-free FBS, 1% antibiotics, 10 μmol/L simvastatin, and 200 μmol/L mevalonic acid, 4 μg/mL dox) for another 48 hours. Because the mevalonate pathway is critical for cell viability, mevalonate supplementation was included in the cholesterol depletion mixture as done in Trinh and colleagues (121 (link)). On day 4, cholesterol depletion was confirmed through Promega's cholesterol Glo assay, and cells were seeded for invasion assays.